Actively Recruiting

Age: 18Years - 70Years
All Genders
NCT06002711

Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study

Led by RenJi Hospital · Updated on 2025-08-08

500

Participants Needed

2

Research Sites

226 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

1. To retrospectively explore the feasibility of multi-dimensional heterogeneity imaging features of MRI in predicting the status of key gene mutations in high-grade gliomas; 2. To prospectively explore the correlation between multi-dimensional heterogeneous MRI image features and prognosis of high-grade glioma patients.

CONDITIONS

Official Title

Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants aged 18 to 70 years, of any gender
  • Confirmed postoperative pathology of adult diffuse glioma (WHO Grade III-IV) for retrospective study
  • Standard MR contrast-enhanced imaging performed within 10 days before surgery for retrospective study
  • No prior radiotherapy or chemotherapy before surgery for retrospective study
  • No significant comorbidities or other tumors
  • Molecular testing results available (IDH, MGMT, 1p19q, TERT, CDKN2A/B, BRAF) for retrospective study
  • Comprehensive clinical and follow-up data available for retrospective study
  • Clinically suspected high-grade gliomas preoperatively, with final pathology confirming diagnosis for prospective study
  • Stable vital signs and ability to cooperate for a 40-minute MR scan for prospective study
  • Signed informed consent for prospective study
Not Eligible

You will not qualify if you...

  • MRI images with artifacts or intratumoral hemorrhage for retrospective study
  • Incomplete clinical data for retrospective study
  • Claustrophobia or inability to undergo MRI scans for prospective study
  • History of allergic reactions to MRI contrast agents for prospective study
  • Unsuitability for prolonged MRI scans due to other reasons for prospective study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Department of Radiology, Renji Hospital School of Medicine, Shanghai Jiao Tong University

Shanghai, Select A State Or Province, China, 200127

Actively Recruiting

2

Department of Radiology, Renji hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China, 200127

Active, Not Recruiting

Loading map...

Research Team

Y

Yan Zhou, MD,PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here